GE HealthCare Technologies is a medical technology, pharmaceutical diagnostics, and digital solutions company. Co. has four segments: Imaging, which includes a portfolio of medical imaging solutions; Ultrasound, which includes ultrasound consoles and probes, handheld devices, intraoperative imaging systems, visualization software, service capabilities, and digital solutions; Patient Care Solutions, which includes monitoring, anesthesia and respiratory care, maternal infant care, and diagnostic cardiology solutions, consumables, service capabilities, and digital solutions; and Pharmaceutical Diagnostics, which are imaging agents that include contrast media and radiopharmaceuticals. The GEHC average annual return since 2022 is shown above.
The Average Annual Return on the GEHC average annual return since 2022 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether GEHC average annual return since 2022 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the GEHC average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|